The XLIV Paraguay Sessions Have Started – Day 1

The day is finally here. The XLIV SOLACI Sessions (15th Southern Cone Region) began in Paraguay, with participants attending both in person and virtually, and the participation of prestigious interventional cardiologists from Paraguay and Latin America.

The event is a scientific success, with over 200 registrations for in-person attendance and 700+ people connecting via Zoom.

 

The first day of activities began with the opening ceremony, where the President of the Paraguayan Society of Cardiology and Cardiovascular Surgery (SPCyCC), Dr. Alberto Marecos Baruja, and the SOLACI Sessions Director, Dr. Gustavo Vignolo, welcomed the attendees to what would be an intense day of theoretical and practical learning in cardiovascular interventionism.

The morning modules focused on Chronic Ischemic Heart Disease and Non-ST Elevation Acute Coronary Syndromes, with important presentations on chronic coronary syndromes (CCS), pharmacological strategies, revascularization in CCS, acute coronary syndromes, multi-vessel disease, and acute coronary syndromes in young women (among other topics).

Afterwards, the Director of the SolSOLACI Program, Dr. Marcelo Halac, opened the session on charitable pediatric cases and presented the main achievements of a chapter that has already been involved in over 70 charitable cases throughout the continent. In this sense, he explained that the main objective of the program is facilitating access to cardiovascular procedures for low-income patients who lack medical coverage in Latin American and Caribbean countries.

In the afternoon, there were sessions on antiplatelet and anticoagulation therapies (with interesting presentations on double antiplatelet therapy, post-angioplasty anticoagulation, post-TAVR antithrombotic treatment, bleeding complications, and more), and on Acute Coronary Syndromes with ST Elevation (where relevant topics such as infarct codes, pharmaco-invasive strategies, late acute infarction, and clinical cases were discussed). 

We hope you will join us to continue enjoying an unmissable event for all interventional cardiologists from Paraguay and the region.

« of 2 »

Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

How to apply for the SOLACI Research 2025 Grant? Step-by-step explanation video

You can now rewatch the virtual event we held on April 9th, where we thoroughly reviewed the steps to apply for the SOLACI Research...

April 9 – How to Apply for the SOLACI Research Grant 2025? Virtual Zoom Event

The Latin American Society of Interventional Cardiology invites you to a new virtual event hosted by the SOLACI Research Department, aimed at clarifying doubts,...

Watch our event on Evidence and Controversies of Renal Denervation in 2025

You can now watch our event, held in collaboration with Medtronic, titled "Evidence and Controversies of Renal Denervation in 2025." The event featured international experts...

March 26 – SOLACI Webinar: Evidence and Controversies in Renal Denervation in 2025

The Latin American Society of Interventional Cardiology invites you to a new virtual event supported by Medtronic. On this occasion, we will hold a 60-minute...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Percutaneous Tricuspid Valve Replacement with Lux-Valve

Tricuspid regurgitation (TR) is a condition associated with poor quality of life, frequent hospitalizations due to heart failure, and increased mortality, even under optimal...

Transcatheter Pulmonary Valve Implantation with a Self-Expanding Valve: Outcomes at 3 Years

Pulmonary regurgitation (PR) is a common condition in patients who have undergone surgical repair of Tetralogy of Fallot or other pathologies involving the right...

Radial Patency in Coronary Procedures: Is Heparin Enough or Should We Aim for Distal Transradial Access?

Transradial access is the preferred route in most coronary procedures due to its proven reduction in mortality compared to transfemoral access. However, one of...